Investor Relations Home
|IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market.|
The Company was incorporated in California in February 1989 as IRIS Medical Instruments, Inc. In November 1995, we changed our name to IRIDEX Corporation and reincorporated in Delaware. Investors and others should note that we announce material financial information to our investors using SEC filings, press releases, our investor relations website, public conference calls and webcasts. We use these channels as well as social media to communicate with investors, customers and the public about our company, our products and other issues. It is possible that the information we post on social media channels could be deemed to be material information. We encourage investors, our customers, and others interested in our company to review the information we post on our Facebook page (www.facebook.com/IRIDEX) and Twitter feed (https://twitter.com/IRIDEX).
|01/12/15||IRIDEX Announces Preliminary Unaudited Revenues for 2014 Fourth Quarter and Full Year; 2015 Revenue Outlook|
|MOUNTAIN VIEW, Calif., Jan. 12, 2015 /PRNewswire/ -- IRIDEX Corporation (Nasdaq:IRIX) today reported preliminary revenues of approximately $11.5 to $11.7 million and $42.5 to $42.7 million for the fourth quarter and full year 2014, respectively. Preliminary revenues in the fourth quarter exceeded the high end of the Company's guidance and were driven by a continued strong uptick in sales of MicroPulse™ laser systems both in the U.S. and internationally. Management had projected revenues to be be... |
|12/31/14||Medical Laser Veteran George R. Marcellino, Ph.D. Appointed to IRIDEX Board of Directors|
|MOUNTAIN VIEW, Calif., Dec. 31, 2014 /PRNewswire/ -- IRIDEX Corporation (NASDAQ:IRIX) announced today that it has appointed ophthalmology and medical laser executive George R. Marcellino, Ph.D., to its Board of Directors, effective immediately. Dr. Marcellino is a co-founder of Sunnyvale, CA-based OptiMedica Corporation, and he fills the seat vacated by James B. Hawkins, who is rotating off the Board after 7 years of service to the IRIDEX shareholders.
Will Moore, IRIDEX President and CEO,... |
|11/19/14||IRIDEX Secures Large Tender from Government of Zambia for Ophthalmology Laser Equipment|
|Expanding Tender Activity in Developing Economies Demonstrates Recognition of Low Cost, Durable Therapeutic Advantages of Laser-Based Treatments for Ophthalmologic Diseases
MOUNTAIN VIEW, Calif., Nov. 19, 2014 /PRNewswire/ -- IRIDEX Corporation (Nasdaq:IRIX) announced today that it has been awarded a competitive tender for more than $350,000 in ophthalmology laser equipment by the government of Zambia.
Will Moore, IRIDEX President and CEO said, "The incidence of diabetes continues to gr... |
|10/30/14||IRIDEX Reports 2014 Third Quarter, Nine-Month Results|
|MOUNTAIN VIEW, Calif., Oct. 30, 2014 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter and nine months ended September 27, 2014.
Revenues were $10.1 million in the third quarter of 2014, a record for the company's third quarter and up 6% from $9.5 million in the 2013 third quarter. Revenues for the first nine months of 2014 were $31.0 million, up 12% from $27.7 million in the first nine months of last year.
Gross margin for the quar... |
|Primary IR Contact|
Chief Financial Officer and Chief Operating Officer
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.